Skip to content
Log In

Command Dialog

Entos (Iambic Therapeutics)

SERIES
Series A
san diego, usa
Last funded
Active

ai drug discovery, generative chemistry

Latest Funding
Series A
$53 million
Valuation
N/A

Market Focus

Series A

AI Products

OrbNet AI-driven drug design platform

AI Capabilities

Growth Predictions

Recent Activity

1.
https://www.fiercebiotech.com/medtech/entos-collects-53m-bring-quantum-tech-ai-drug-design

Company Information

Company Name
Entos (Iambic Therapeutics)
Headquarters
san diego, usa
Twitter
@N/A

Startup Stats

Stage
SERIES
Locationsan diego, usa
Market StageSeries A
Last Funding

Similar Startups